<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Local anesthetic dosing for pediatric regional anesthesia*&lt;sup&gt;[1,2]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Local anesthetic dosing for pediatric regional anesthesia*<sup>[1,2]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Local anesthetic dosing for pediatric regional anesthesia*<sup>[1,2]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="25%"></colgroup><colgroup width="50%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1" colspan="2">Regional anesthetic/usual drugs</td> <td class="subtitle1">Maximum recommended doses of LA</td> </tr> <tr class="divider_bottom divider_top"> <td colspan="2"><strong>Wound infiltration:</strong> <ul class="decimal_heading"> <li>0.2% Ropivacaine (2 mg/mL) or </li> <li>0.25% Bupivacaine (2.5 mg/mL) </li> </ul> </td> <td> <ul> <li>Use minimal volume required, not to exceed maximum recommended doses </li> </ul> </td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Peripheral nerve blocks:</strong> <ul class="decimal_heading"> <li>0.2% Ropivacaine (2 mg/mL) or </li> <li>0.25% Bupivacaine: (2.5 mg/mL) </li> </ul> </td> <td> <ul> <li>Upper extremity blocks (eg, brachial plexus), lower extremity blocks (eg, femoral, sciatic, popliteal, or adductor canal block), interfascial plane blocks (TAP, rectus sheath, fascia iliaca ): 0.5 to 1.5 mg/kg <ul> <li>Bupivacaine: 0.2 to 0.6 mL/kg </li> <li>Ropivacaine: 0.25 to 0.75 mL/kg </li> <li>With ultrasound guidance, lower volumes may be adequate for nerve blocks. Significant local anesthetic absorption may occur with extended fascial plane blocks </li> </ul> </li> <li>Ilioinguinal /Iliohypogastric: 0.25 mg/kg bupivacaine or 0.2 mg/kg ropivacaine (0.1 to 0.2 mL/kg of either drug is usually sufficient for this block) </li> </ul> </td> </tr> <tr class="divider_bottom"> <td colspan="2"><strong>Caudal block:</strong> <ul class="decimal_heading"> <li>0.2% Ropivacaine (2 mg/mL) </li> <li>0.25% Bupivacaine: (2.5 mg/mL) </li> </ul> </td> <td> <ul> <li>Modify single-shot volume to achieve appropriate dermatomal level: <ul> <li>To a T<sub>10</sub> level: 0.5 mL/kg (ie, 1 mg/kg ropivacaine or 1.25 mg/kg bupivacaine) </li> <li>T<sub>10</sub> to low-thoracic level: 1 mL/kg (ie, 2 mg/kg ropivacaine or 2.5 mg/kg bupivacaine) </li> </ul> </li> <li>Maximum volume for single shot caudal: &lt;20 mL </li> </ul> </td> </tr> <tr class="divider_bottom"> <td colspan="3"><strong>Lumbar or thoracic epidural</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="2"><strong>Intraoperative loading dose:</strong> <ul class="decimal_heading"> <li>0.2% Ropivacaine (2 mg/mL) </li> <li>0.25% Bupivacaine: (2.5 mg/mL) </li> </ul> </td> <td> <ul> <li>Usual initial lumbar loading dose: <ul> <li>0.5 mL/kg (ie, 2 mg/kg ropivacaine or 2.5 mg/kg bupivacaine) </li> <li>Maximum recommended volume &lt;15 mL (fractionated) </li> </ul> </li> </ul> <ul> <li>Usual initial thoracic loading dose: <ul> <li>0.3 mL/kg (ie, 0.6 mg/kg ropivacaine or 0.75 mg/kg bupivacaine), not to exceed 0.68 mL/kg = 1.7 mg/kg </li> <li>Maximum recommended volume &lt;8 mL (fractionated) </li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1 divider_bottom border_bottom_thick" colspan="2" rowspan="2"> <p><strong>Postoperative epidural infusion</strong></p> Usual drug concentrations: <ul class="decimal_heading"> <li>Bupivacaine: 0.0625 to 0.1% (0.625 to 1 mg/mL) </li> <li>Ropivacaine: 0.1% (1 mg/mL) </li> <li>2-chlorprocaine: 1.5% (15 mg/mL) </li> </ul> </td> <td class="divider_bottom">Continuous infusion: <ul class="decimal_heading"> <li>&lt;3 months of age: Bupivacaine, ropivacaine, or chloroprocaine 0.2 mg/kg/hour </li> <li>3 months to ≤1 year of age: Bupivacaine, ropivacaine, or chloroprocaine: 0.3 mg/kg/hour </li> <li>&gt;1 year of age: Bupivacaine or ropivacaine: 0.4 mg/kg/hour, chloroprocaine: 0.5 mg/kg/hour </li> </ul> </td> </tr> <tr class="divider_bottom border_bottom_thick"> <td>PCEA (for children &gt;30 kg and capable of understanding pump function): <ul class="decimal_heading"> <li>Demand dose: 0.5 to 3 mL/dose (if utilized) </li> <li>Lockout interval: 30 to 60 minutes </li> <li>Continuous infusion: Usually ≤15 mL/hour for lumbar epidural, ≤7.5 mL/hour for thoracic epidural, for children &gt;60 kg </li> <li>Maximum hourly dose (ie, continuous infusion dose + PCEA demand doses): ≤0.4 mg/kg/hour </li> </ul> </td> </tr> <tr class="divider_bottom divider_top"> <td class="subtitle1" colspan="2">Maximum allowable doses<sup>¶</sup></td> <td rowspan="6"> </td> </tr> <tr class="divider_bottom divider_top"> <td class="subtitle2">Drug:</td> <td class="subtitle2">Maximum dose (mg/kg) without/with epinephrine</td> </tr> <tr class="divider_top"> <td>Lidocaine</td> <td class="centered">4.5/7</td> </tr> <tr> <td>Bupivacaine</td> <td class="centered">2.5/3</td> </tr> <tr> <td>Ropivacaine</td> <td class="centered">3/3.5</td> </tr> <tr> <td>2-Chloroprocaine</td> <td class="centered">11/14</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table shows evidence and consensus based recommendations for safe and effective doses of local anesthetics for regional analgesia in children. Maximum doses represent general guidelines. Local anesthetic systemic toxicity can occur with doses below the recommended range, particularly with intravascular injection. Doses in excess of the recommended maximums have been administered without toxicity. Familiarity with and utilization of ultrasound guidance for peripheral nerve blocks may improve safety and achieve more reliable analgesia with a decreased in drug dose. If an increased volume of local anesthetic is required a lower concentration may be considered.</div><div class="graphic_footnotes">TAP: transversus abdominus plane.<br/>	

	* Experience in performing central blocks in children is mandatory. All central local anesthetic solutions must be preservative-free and doses administered incrementally with hemodynamic and respiratory monitoring. Ultrasound guidance is recommended for all peripheral nerve blocks.<br/>	

	¶ Single or fractionated single dose only based on lean body weight; not infusion or repetitive dose within 24 hours.</div><div class="graphic_reference">References:

	<ol>
<li>Vittinghoff M, Lönnqvist PA, Mossetti V, et al. Postoperative pain management in children: Guidance from the pain committee of the European Society for Paediatric Anaesthesiology (ESPA Pain Management Ladder Initiative). Paediatr Anaesth 2018; 28:493.</li>
<li>Suresh S, Ecoffey C, Bosenberg A, et al. The European Society of Regional Anaesthesia and Pain Therapy/American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Reg Anesth Pain Med 2018; 43:211.</li>
</ol></div><div id="graphicVersion">Graphic 127523 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
